恒瑞医药(01276)9月26日斥资6135.69万元回购88.34万股A股

Group 1 - The company, Heng Rui Medicine, announced a share buyback plan on September 26, 2025, with an investment of 61.3569 million RMB to repurchase 883,400 A-shares [1] - The repurchase price per share ranges from 69.25 to 69.81 RMB [1]